Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Simple Electrocardiographic Measures Improve Sudden Arrhythmic Death Prediction in Coronary Disease
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review
Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop